OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries
-
LVMH 2025 net profit drops 13% to 10.9 bn euros
-
Philip Glass pulls Kennedy Center premiere after Trump takeover
-
Slot says Liverpool must fix 'very bad cocktail'
-
How to assess microplastics in our bodies? Scientists have a plan
-
US sued over deadly missile strikes on alleged drug boats
-
Trump ally Asfura sworn in as Honduras president
-
US border enforcer set to leave Minneapolis as Trump tries to calm crisis
-
US consumer confidence drops to lowest level since 2014
-
Teens underwhelmed by France's social media ban
-
Trump ally Nasry Asfura sworn in as Honduras president
-
BAFTAs nominees in main categories
-
'Doomsday Clock' moves closer to midnight, a year into Trump term
-
Mexico exports jump in 2025 despite US trade tensions
-
Arteta issues rallying cry after Arsenal wobble
-
PSG hoping Newcastle visit can spark another run to Champions League glory
-
Real Madrid's Arbeloa like one of my 'children', says Mourinho
-
Jury selection begins in landmark social media addiction trial
-
Gazans long for reopening of 'lifeline' Rafah crossing
-
American influencer shares 'another' Africa on tour
-
Guardiola blames Man City team for Haaland struggles
-
Germany takes aim at 'bureaucratic jungle' with welfare reforms
-
French aircraft carrier heads to North Atlantic amid Greenland tensions
-
Brook's masterclass leaves Sri Lanka reeling in series decider
-
Amy Winehouse's friends 'took advantage' of father, UK court told
-
Blazy takes flight of fancy with bird-themed Chanel show
-
Comparing Yamal to Messi 'crazy': Barca's Olmo
-
EU to show Google how to open up to rival AI services
-
'One Battle After Another' and 'Sinners' top BAFTA nods
-
Spain to regularise 500,000 undocumented migrants
-
Alcaraz sweeps into maiden Melbourne semi as Gauff gone in 59 minutes
-
'Just a show': Ukrainians believe Russia wants war, not talks
-
Alcaraz rolls into maiden Melbourne semi-final and date with Zverev
-
Stocks gain tracking tech, Fed and trade
-
Greece probes biscuit factory fire as fifth victim found
-
Spain unemployment drops below 10% in first since 2008
-
Trump says Iran wants talks as US aircraft carrier deploys
-
Gauff defends epic racquet smash and hits out at it being broadcast
-
Germany offers 1 mn euro reward for Berlin blackout culprits
-
Anger as branch of ICE to help with security at Winter Olympics
-
'American Doctor' tells of brutality in Israel-Hamas war
-
Gauff gone in 59 minutes as Svitolina sets up Sabalenka semi-final
-
Greece probes factory fire as fifth victim found
-
China's Anta Sports to become top Puma shareholder
-
Svitolina stuns Gauff in 59 minutes to sail into Australian Open semis
-
Rule of law 'routinely challenged': ICC head
-
Rights group says confirmed Iran protest toll over 6,000
-
Stocks track Wall St gains, Seoul brushes off tariff threat
-
Japan PM says US alliance would collapse if Tokyo ignored Taiwan crisis
-
Pain-free Zverev blasts into Australian Open semi-finals
-
UK tour agency to host golf tournament in North Korea
NYSE - LSE
| CMSC | -0.16% | 23.7406 | $ | |
| CMSD | -0.42% | 24.06 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| NGG | 1.67% | 83.985 | $ | |
| GSK | 1.52% | 51.095 | $ | |
| BTI | 1.62% | 59.96 | $ | |
| RIO | 1.88% | 92.2 | $ | |
| BCC | -2.38% | 81.46 | $ | |
| RYCEF | 0.87% | 17.15 | $ | |
| RBGPF | -1.01% | 82.4 | $ | |
| BP | 1.55% | 37.34 | $ | |
| AZN | 1.51% | 95.67 | $ | |
| VOD | 1.49% | 14.445 | $ | |
| BCE | 1.14% | 25.44 | $ | |
| JRI | -0.55% | 13.655 | $ | |
| RELX | -4.79% | 37.705 | $ |
OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries
BELLEVUE, WA / ACCESS Newswire / January 27, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced the official closing of its acquisition of Woori IO, the reaffirmation of long-term equity alignment by Woori IO's historical shareholders, and the initiation of a strategic review regarding a potential combination of its medical device subsidiaries.
Woori IO Acquisition Closed
OSRH confirmed that the previously announced acquisition of Woori IO and the related share exchange transaction have been formally completed in Korea, effective January 26, 2026. As a result, Woori IO is now a consolidated subsidiary of OSRH, further strengthening the Company's medical device and digital health platform, particularly in noninvasive glucose monitoring and wearable health technologies.
Three-Year Equity Alignment Secured by Legacy Shareholder
In connection with the closing, historical shareholders of Woori IO reaffirmed a three-year equity alignment framework, under which they have agreed to exchange their equity interests in OSR Holdings Co., Ltd. (OSRK) into NASDAQ-listed OSRH common stock only at a reference price of USD $10.00 per share. This voluntary structure is designed to prevent near-term dilution and align legacy shareholders with the long-term performance of OSRH's public equity, reflecting confidence in the Company's strategic direction and capital markets positioning.
Strategic Review of Medical Device Subsidiaries
Separately, Peter Hwang, CEO of OSRH, indicated that the Company is conducting a strategic review of a potential combination of its two medical device subsidiaries, Woori IO and RMC, with the goal of forming a new, integrated medical technology and distribution company.
The review reflects the complementary strengths of the two businesses, including Woori IO's digital health and wearable-device capabilities, supported by collaboration initiatives with Samsung Electronics, along with RMC's established hospital network in Korea and commercial revenue history. OSRH is evaluating whether a combined platform could support a standalone IPO in Korea, subject to market conditions, regulatory considerations, and board approvals.
Positioned for Continued Value Creation
"With the Woori IO acquisition now closed, long-term alignment secured from legacy shareholders, and a strategic review underway to unlock synergies across our medical device businesses, we believe OSR Holdings is well positioned to pursue multiple, disciplined pathways to value creation," said Mr. Hwang.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding expected benefits of the Woori IO acquisition, shareholder alignment, potential strategic transactions, and future business plans. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially, including regulatory, integration, market, execution, and capital markets risks, as well as other risks described in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to update any forward-looking statements, except as required by law.
About OSR Holdings, Inc.
OSR Holdings, Inc. (NASDAQ:OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness. Through its subsidiaries, OSRH is engaged in immuno-oncology, regenerative biologics, and medical device technologies. Its vision is to build a portfolio of breakthrough healthcare solutions to improve global health outcomes. Learn more at www.OSR-Holdings.com.
About Woori IO Co., Ltd.
Woori IO is a South Korea-based medical device company developing noninvasive biosensing technologies for glucose monitoring and beyond. Its proprietary NIRS-based system enables accurate, pain-free glucose tracking and is designed for integration into wearables. The company has been recognized by a leading global consumer electronics company's startup program for its innovation in NIGM technology.
CONTACT:
Media & Investor Contacts
OSR Holdings, Inc.
Investor Relations
[email protected]
SOURCE: OSR Holdings, Inc.
View the original press release on ACCESS Newswire
D.Moore--AMWN
